BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 9.10.2008

Draft Guidance for Industry: Potency Tests for Cellular and Gene Therapy Products; Availability

The Food and Drug Administration (FDA) is announcing the availability of a draft document entitled "Guidance for Industry: Potency Tests for Cellular and Gene Therapy Products" dated October 2008. The draft guidance document provides manufacturers of cellular and gene therapy (CGT) products with recommendations for developing tests to measure potency. The recommendations are intended to clarify the potency information needed to support an Investigational New Drug Application (IND) or a Biologics License Application (BLA).

Source: Federal Register — Food and Drug AdministrationOpen original release →